Mannitol versus furosemide in patients with thoracic malignancies who received cisplatin-based chemotherapy using short hydration: A randomized phase II trial.

Eriko Murakami Hiroaki AkamatsuShunsuke TeraokaToshiaki TakakuraEri TakaseMasanori TanakaTakahiro KakiYuhei HarutaniKatsuyuki FurutaTakeya SugimotoRyota ShibakiDaichi FujimotoAtsushi HayataYuichi OzawaMasanori NakanishiYasuhiro KohToshio ShimokawaNobuyuki Yamamoto

Published in: Cancer medicine (2024)

Mannitol should remain the standard diuresis in CDDP-based chemotherapy assessed by conventional CTCAE grading, but furosemide can be room for consideration when assessed by actual serum Cr level and Cr clearance.

Keyphrases

locally advanced
spinal cord
squamous cell carcinoma
open label
rectal cancer
radiation therapy